Rainier Investment Management buys $25,240,110 stake in MEDNAX Inc (MD)

MEDNAX Inc (MD) : Rainier Investment Management scooped up 88,450 additional shares in MEDNAX Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 383,880 shares of MEDNAX Inc which is valued at $25,240,110.MEDNAX Inc makes up approximately 1.17% of Rainier Investment Management’s portfolio.

Other Hedge Funds, Including , First Republic Investment Management boosted its stake in MD in the latest quarter, The investment management firm added 2,147 additional shares and now holds a total of 10,501 shares of MEDNAX Inc which is valued at $690,441. MEDNAX Inc makes up approx 0.01% of First Republic Investment Management’s portfolio.Bronfman E.l. Rothschild boosted its stake in MD in the latest quarter, The investment management firm added 2,231 additional shares and now holds a total of 2,962 shares of MEDNAX Inc which is valued at $194,752. MEDNAX Inc makes up approx 0.03% of Bronfman E.l. Rothschild’s portfolio.Bridgewater Wealth Financial Management boosted its stake in MD in the latest quarter, The investment management firm added 1,573 additional shares and now holds a total of 73,914 shares of MEDNAX Inc which is valued at $4,971,456. MEDNAX Inc makes up approx 1.76% of Bridgewater Wealth Financial Management’s portfolio. P.r. Herzig added MD to its portfolio by purchasing 3,300 company shares during the most recent quarter which is valued at $250,503. MEDNAX Inc makes up approx 0.50% of P.r. Herzig’s portfolio.

MEDNAX Inc closed down -1.29 points or -1.96% at $64.48 with 5,47,880 shares getting traded on Thursday. Post opening the session at $65.59, the shares hit an intraday low of $63.74 and an intraday high of $65.735 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, MEDNAX Inc reported $1.03 EPS for the quarter, missing the analyst consensus estimate by $ -0.04 based on the information available during the earnings call on Jul 28, 2016. Analyst had a consensus of $1.07. The company had revenue of $771.80 million for the quarter, compared to analysts expectations of $774.46 million. The company’s revenue was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.90 EPS.

MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *